Here is the Quote from the Street.
"Arena Pharmaceuticals (ARNA) had a good day yesterday on high volume. Volume registered at 17.4 million as shares closed at $6.50/share having risen $0.30 (4.84%). Shares have held up pretty well, honestly better than we would have expected especially considering the secondary offering which occurred right after the news from the FDA panel. The shares are within shouting distance of their 52-week high, and with news coming up regarding weight drugs it might time for those looking to play this one to start accumulating positions. Although with the current market activity there really is no rush to do this as we think there will be a few large down days in the market between now and then to add to positions."